PHENDIMETRAZINE TARTRATE | WYETH AYERST | ||
35MG | |||
No | No | ||
Expired | Expired | ||
None | None | ||
None | No | ||
PLEGINE is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of greater than or equal to 30 kg/m2 or greater than or equal to 27 kg/m2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia) who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. |
5 | 0 | 3 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
35MG | ** | ** | - | - | 3 |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 3 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|---|---|---|---|---|
****** | ***** **** *** | ***** ************, ***. | *********** | ***\***\*** ****** ******, *********, *** ****** (**) *****, ****** ****** (***) | *** |
****** | ****** | **** ******, *** | *********** | ***** ***** ******* ******, *********, *** **** (**) *****, ****** ****** (***) | *** |
****** | *** **** | ***-****, ***. | *********** | *** ***** **., *******, ************ (**) *****, ****** ****** (***) | *** |
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com